Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.

The lab is led by Mustafa Suleyman, who co-founded DeepMind before Google acquired it in 2014 and only left the company in ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

Microsoft has hired more than 20 artificial intelligence pros from Google’s DeepMind unit in the past six months, ...

As Meta steals AI talents from the tech giants, Google DeepMind CEO believes that money is not the only motivation. He says Meta is not among the top performers in the AI race.

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Two AI models have achieved gold medal standard for the first time in a prestigious competition for young mathematicians – ...